Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by mercedesmanon Apr 22, 2021 10:20pm
116 Views
Post# 33053254

RE:RE:RE:Hot off the press - is it a start.....we'll see....

RE:RE:RE:Hot off the press - is it a start.....we'll see....

Rob got off to a bit of a slow start and Edam was a bit cheesy ...

but overall they did a decent job of laying it out for everyone ... I.e. the next wave of Covid pivoting companies that are set to benefit....

... hint: it involves diagnostics, antibody detection, serology and home testing. 

people need to be able to answer the following questions:

  • Am I still protected by either having had Covid or by the vaccine?
  • is the protection declining over time?
  • is it safe to return to work ?
  • Etc. 

the Covid testing CO's and the vaccine CO's have had their turn.  Now SQI is awaiting its turn ...

... it's next in line. 

... would-be investors just haven't figured that out yet. 
 

Can you say "ground floor opportunity"? 


MM 

 

<< Previous
Bullboard Posts
Next >>